Stay up-to-date on current diabetes themes, proven therapeutic options, and knowledge resources and tools for you and your patients, and find detailed information on Novo Nordisk diabetes products.
Since the launch of its first pen needle in 1985, Novo Nordisk has been committed to enhancing injection experience
by putting technology in patient hands. NovoFine® Plus is the latest example of that commitment.
We have products for rare bleeding disorders, growth hormone-related disorders, and women’s health.
Chronic Weight Management
Find information on our treatment for chronic weight management in adults who are overweight with one weight-related comorbidity or obesity.
jobs in 2017
and more to come in 2018
Novo Nordisk is investing $2 billion in a new pharmaceutical manufacturing facility in Clayton, NC. This expansion will generate more than 700 full-time jobs. Join us on Your Groundbreaking Journey.
Read about our existing facility and the new facility.
Novo Nordisk is a world leader in diabetes care with a presence in Clayton, NC for over 20 years. We are more than 41,400 employees worldwide. Join us!
Get to know us and apply
for a life-changing career!